FindMyKOL

Sarah Thordsen, MD

Basic profile

University of Wisconsin–Madison

ORCID↗NPI↗
✓ Itemized record
RegionMadison, WI · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLEmergingFindMyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Sarah Thordsen is a Cardiology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 16 publications with 542 citations (h-index 7); ClinicalTrials.gov lists 3 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

542citations

Citations across these publications.

7h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    85.5%
    Beta blocker23%
    Metoprolol Succinate57%Carvedilol26%Metoprolol Tartrate17%
    Part D≥94 patients
    Statin20.7%
    Rosuvastatin Calcium54%Atorvastatin Calcium42%Pravastatin Sodium4%
    Part D<11 patients

    + 11 more classes in this area

  • Blood & clotting

    9.2%
    Factor Xa inhibitor4.7%
    Eliquis82%Xarelto18%
    Part D<11 patients
    P2Y12 inhibitor2.6%
    Clopidogrel100%
    Part D≥22 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    5.3%
    SGLT2 inhibitor3.2%
    Farxiga75%Jardiance25%
    Part D<11 patients
    Potassium supplement1.3%
    Potassium Chloride100%
    Part D≥14 patients

    + 1 more class in this area

Where care is delivered (Part B)68.5% facility · 31.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”